Trials / Recruiting
RecruitingNCT06140992
PaCIFiC-CUP Classifies Cancer of Unknown Primary
PaCIFiC-CUP:Pan-Cancer Integrated Fingerprinting Classifier for Identifying the Origin of Cancer of Unknown Primary: A Multi-Center Prospective Cohort Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to initially utilize machine learning on pan-cancer DNA methylation data from public databases to construct a DNA methylation classification model (PaCIFiC-CUP, pan-cancer integrated fingerprinting classifier of CUP) for diagnosing various types of cancer, particularly the primary site of cancer of unknown primary. The goal is to achieve diagnosis of cancer pathology type by analyzing the DNA methylation patterns of cancer specimens, thereby guiding subsequent precision treatment for cancer.
Conditions
Timeline
- Start date
- 2023-07-01
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2023-11-21
- Last updated
- 2025-06-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06140992. Inclusion in this directory is not an endorsement.